Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:

    ORCID: 0000-0002-2914-9605

    Publication year:
    All
    1 - 10 out of 11Page size: 10
    1. 2015
    2. Published

      Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity

      Donia, M., Andersen, R., Kjeldsen, J. W., Fagone, P., Munir, S., Nicoletti, F., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 15 Sep 2015, In: Cancer Research. 75, 18, p. 3747-59 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy

      Andersen, Mads Hald, Sep 2015, In: National Cancer Institute. Journal (Online). 107, 9, p. 1-8 djv154.

      Research output: Contribution to journal › Comment/debate › Research › peer-review

    4. Published

      Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies

      Borch, T. H., Donia, M., Andersen, Mads Hald & Svane, Inge Marie, Sep 2015, In: Drug Discovery Today. 20, 9, p. 1127-34 8 p.

      Research output: Contribution to journal › Review › Research › peer-review

    5. Published

      Oncogenic cancer/testis antigens: prime candidates for immunotherapy

      Gjerstorff, M. F., Andersen, Mads Hald & Ditzel, H. J., 30 Jun 2015, In: OncoTarget. 6, 18, p. 15772-87 16 p.

      Research output: Contribution to journal › Review › Research › peer-review

    6. Published

      Profound Endothelial Damage Predicts Impending Organ Failure and Death in Sepsis

      Johansen, M. E., Johansson, P. I., Ostrowski, Sisse Rye, Bestle, Morten Heiberg, Hein, L., Jensen, A. L. G., Søe-Jensen, P., Andersen, Mads Hald, Steensen, M., Mohr, T., Thormar, K., Lundgren, B., Cozzi-Lepri, A., Lundgren, Jens & Jensen, J., Feb 2015, In: Seminars in Thrombosis and Hemostasis. 41, 1, p. 16-25 10 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      The Targeting of Indoleamine 2,3 Dioxygenase -Mediated Immune Escape in Cancer

      Iversen, T. Z., Andersen, Mads Hald & Svane, Inge Marie, Jan 2015, In: Basic & Clinical Pharmacology & Toxicology. 116, 1, p. 19-24 6 p.

      Research output: Contribution to journal › Review › Research › peer-review

    8. Published

      Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

      Hjortsø, M. D., Larsen, S. K., Kongsted, P., Met, Özcan, Frøsig, T. M., Andersen, G. H., Ahmad, S. M., Svane, Inge Marie, Becker, J. C., Straten, P. T. & Andersen, Mads Hald, Jan 2015, In: OncoImmunology. 4, 1, e968480.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. Published

      Establishing the pig as a large animal model for vaccine development against human cancer

      Overgaard, N. H., Frøsig, T. M., Welner, S., Rasmussen, M., Ilsøe, M., Sørensen, M. R., Andersen, Mads Hald, Buus, Søren & Jungersen, G., 2015, In: Frontiers in Genetics. 6, 12 p., 286.

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. Published

      Indoleamine 2,3-dioxygenase vaccination

      Andersen, Mads Hald & Svane, Inge Marie, 2015, In: OncoImmunology. 4, 1, p. 1-3 3 p., e983770.

      Research output: Contribution to journal › Journal article › Research › peer-review

    11. Published

      Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes

      Køllgaard, T., Ugurel-Becker, S., Idorn, M., Andersen, Mads Hald, Becker, J. C. & thor Straten, E. P., 2015, In: P L o S One. 10, 7, 14 p., e0131934.

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1 2 Next

    ID: 13571778